The Inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines

Current Medicinal Chemistry

Volumn 19, Issue 1, 2012, Pages 145-151

  Ciolczyk Wierzbicka D ^a   Gil, D ^a   Laidler, P ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

AKT; Cell cycle; ERK; Melanoma; N cadherin; Proliferation; SiRNA; catenin

Indexed keywords

BETA CATENIN; BROXURIDINE; CRYSTAL VIOLET; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; PROTEIN P15; PROTEIN P16; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MEDIATOR; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN METASTASIS; TUMOR CELL LINE; TUMOR LOCALIZATION; WESTERN BLOTTING;

EID: 84857553466     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803414006     Document Type: Article

References (38)

1. Freemont, A.J.; Hoyland, J.A. Cell adhesion molecules. J. Clin. Pathol., 1996, 49, 321M-330M
2. Li, G.; Satyamoorthy, K.; Herlyn, M. Dynamic of cell interactions and communications during melanoma development. Crit. Rev. Oral Med., 2002, 13, 62-70 (Pubitemid 34792761)
3. Bozzo, J.; Dulsat, C. Therapeutic target for melanoma. Drug Future, 2008, 33(7), 615-631
4. Sanders, D.S.; Blessing, K.; Hassan, G.A.; Bruton, R.; Marsden, J. R.; Jankowski, J. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Br. Med. J., 1999, 52, 151-157 (Pubitemid 29277155)
5. Hirohashi, S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol., 1998, 153, 333-339. (Pubitemid 28373643)
6. Hsu, M.; Meier, F.; Nesbit, M.; Hsu, J.; Belle, P.; Elder, D.; Herlyn, M. Ecadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol., 2000, 156, 1515-1525 (Pubitemid 30646691)
7. Ciołczyk-Wierzbicka, D.; Amoresano, A.; Casbarra, A.; Hoja-ukowicz, D.; Lityńska, A.; Laidler, P. The structure of the oligosaccharides of N-cadherin from human melanoma cell lines. Glycoconjugate J., 2003, 20 (7-8), 483-492
8. Laidler P., Litynska A., Hoja-Łukowicz D., Łabȩ dź, M., Przybyło, M., Ciołczyk-Wierzbicka, D., Pocheć E.,. Trȩbacz, E., Kremser, E. Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immmunol. Immun., 2006, 55 (1), 112-118 (Pubitemid 41783301)
9. Hsu, M.; Wheelock, M.; Johnson, K.; Herlyn, M. Shift in cadherin profiles between human normal melanocytes and melanomas. Soc. Investig. Dermatol., 1996, 1, 188-194 (Pubitemid 126759364)
10. Jacobs, K.; Feys, L.; Vanhoecke, B.; Van Marck, V.; Bracke, M. P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude mice. Eur J Cancer Prev., 2011, 20(3),207-16.
11. Kuphal, S.; Martyn, A.C.; Pedley, J.; Crowther, L.M.; Bonazzi, V.F.; Parsons, P.G.; Bosserhoff, A.K.; Hayward, N.K.; Boyle, G.M. H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res., 2009, 22(3), 296-306
12. Maret, D.; Gruzglin, E.; Sadr, M.S.; Siu, V.; Shan, W.; Koch, A.W.; Seidah, N.G.; Del Maestro, R.F., Colman D.R. Surface expression of precursor Ncadherin promotes tumor cell invasion. Neoplasia, 2010, 12(12),1066-80.
13. Aplin, A.; Howe, A, Juliano R.L. Cell adhesion molecules, signal transduction and cell growth. Curr. Option Cell Biol., 1999, 11, 737-744
14. Johnson, J. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer and Metastasis Rev., 1999, 18, 345-357 (Pubitemid 30104068)
15. Hazan, R.B.; Phillips, G. R.; Qiao, R. F.; Norton, L.; Aaronson, S. A. Exogenous expression of N-cadherin in breast cancer cell induces cell migration, invasion and metastasis. J Cell Biol., 2000, 148,779-790
16. Derycke, L. D. M.; Bracke, M. E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signaling. Int. J. Dev. Biol., 2004, 48, 463-476 (Pubitemid 39360397)
17. Williams, M.R.; Duncan, G.; Riach, R.A.; Webb, S.F. Acetylcholine receptors are coupled to mobilization of intracellular calcium in cultured human lens cell. Exp. Eye Res., 1993, 57, 381-384 (Pubitemid 23288818)
18. Christofori, G. New signals from the invasive front. Nature, 2006, 44(25), 444-450. (Pubitemid 44050139)
19. Gil, D.; Ciołczyk-Wierzbicka, D.; Dulińska-Litewka, J.; Zwawa, K.; McCubrey, J.A.; Laidler, P. The mechanism of contribution of integrin linked kinase (ILK) to epithelial mesenchymal transition (ETM). Adv. Enzyme Regulation., 2011, 51,195-207
20. Florenes, V.A.; Maelandsmo, G.M.; Kerbel, R.S. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Am. J. Pathol., 1998, 153, 305-312 (Pubitemid 28317534)
21. Tran, NL.; Adams, DG.; Vaillancourt RR.; Heimark, R. Signal transduction from N-cadherin increases Bcl-2. J Biol. Chem., 2002, 277, 32905-32914
22. Hulit, J.; Suyama, K.; Chung, S.; Keren, R.; Agiostratidou, G.; Shan, W.; Dong, X.; Williams, T.M.; Lisanti, M.P.; Knudsen, K.; Hazan, R. N-cadherin signalling potentiates tumor metastasis via enhanced extracellular signalregulated kinase activation. Cancer Res., 2007, 67(7), 3106-3116 (Pubitemid 46724847)
23. Tetsu, O.; McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398, 422-426 (Pubitemid 29180374)
24. Wu, D.; Pan, W. GSK3β: multifaceted kinase in Wnt signalling. Trends in Biochem. Sci., 2010, 35(3), 161-168
25. Smalley, K.S. Understanding melanoma signalling networks as the basis for molecular target therapy. J. Invest. Dermatol, 2010, 130, 28-37
26. Li, K.; He, W.; Lin, N.; Wang, X.; Fan, Q. N-cadherin knock-down decreases invasiveness of oesophageal squamous cell carcinoma in vitro. World J. Gastroentero., 2009, 15(6), 697-704
27. Diehl, JA.; Cheng, M.; Roussel, M.F.; Sherr C.J. Glycogen synthase kinase-3 beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev., 1998, 12(22), 3499-511 (Pubitemid 28553242)
28. Behrens, J. von Kries, JP.; Kuhl, M.; Bruhn, L.; Wedlich, D. Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 1996, 382, 638-642 (Pubitemid 26268958)
29. Fang, D.; Hawke, D.; Zheng, Y.; Xia, Z.; Meisenhelder, J.; Nika, H.; Mills, G.; Kobayashi, R.; Hunter, T.; Lu, Z. Phosphorylation of beta -catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem., 2007, 282(15), 11221-11229 (Pubitemid 47100795)
30. Taurin, S.; Sandbo, N.; Qin, Y.; Browing, D.; Dulin N.O. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem., 2006, 281(15), 9971-9976 (Pubitemid 43864529)
31. Spofford, L.S.; Abel, E.V.; Boisvert-Adamo, K.; Aplin, A.E. Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signalling and contributes to G1-S progression. J. Biol. Chem., 2006, 281(35), 25644-51 (Pubitemid 44401953)
32. Bhatt, K V .; Spofford, L S.; Aram, G.; McMullen, M.; Pumiglia, K., Aplin, A E. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signalling Oncogene, 2005, 24, 3459-3471 (Pubitemid 40756247)
33. Florenes, V.A.; Faye, R.S.; Maelandsmo, G.M. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin. Cancer Res., 2000, 6, 3614-3620
34. Soledad, R. A.; Orliz, P.; Pollan, M.; Perez-Gomez, B.; Sanchez, L.; Acuna, M. J.; Pajares, R.; Martinez-Tello, F. J.; Hortelano, C.M.; Piris, M.A.; Rodrigues-Peralto, J. L. Progression in cutaneous malignant melanoma is associated with distinct expression profiles. A tissue microarray based - study. Am. J. Pathol., 2004, 164, 193-203. (Pubitemid 38364604)
35. Rössig, L.; Jadidi, A.S.; Urbich, C.; Badorff, C.; Zeiher, A.M. Akt- Dependent Phosphorylation of p21Cip1 Regulates PCNA Binding and Proliferation of Endothelial Cells Dimmeler S. Mol. Cell Biol., 2001, 21(16), 5644-5657 (Pubitemid 32702467)
36. Hanada, M.; Feng, J.; Hemmings, B. Structure, regulation and function of PKB/ATK-a major therapeutic target. BBA-Proteins Proteom., 2004, 1697(1-2), 11-31
37. Li, Y., Dowbenko, D., Lasky, LA. AKT/PKB phosphorylation of p21 Cip/WAF1 enhances protein stability of p21 Cip/WAF1 and promotes cell survival. J. Biol. Chem., 2002, 277(13), 11352-11361 (Pubitemid 34952901)
38. Zhou, B.P.; Liao, Y.; Xia, W.; Spohn, B.; Lee, M.H.; Hung, M-Ch. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biol., 2001, 3, 245-252 (Pubitemid 32201319)